- Home
- XTNT vs ATLX Comparison
XTNT vs ATLX Comparison
Compare XTNT & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- ATLX
- Stock Information
- Founded
- XTNT N/A
- ATLX 2011
- Country
- XTNT United States
- ATLX Brazil
- Employees
- XTNT N/A
- ATLX N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- XTNT Health Care
- ATLX Industrials
- Exchange
- XTNT Nasdaq
- ATLX Nasdaq
- Market Cap
- XTNT 60.9M
- ATLX 68.5M
- IPO Year
- XTNT N/A
- ATLX N/A
- Fundamental
- Price
- XTNT $0.62
- ATLX $4.47
- Analyst Decision
- XTNT
- ATLX Strong Buy
- Analyst Count
- XTNT 0
- ATLX 2
- Target Price
- XTNT N/A
- ATLX $22.25
- AVG Volume (30 Days)
- XTNT 96.0K
- ATLX 301.5K
- Earning Date
- XTNT 08-07-2025
- ATLX 08-08-2025
- Dividend Yield
- XTNT N/A
- ATLX N/A
- EPS Growth
- XTNT N/A
- ATLX N/A
- EPS
- XTNT N/A
- ATLX N/A
- Revenue
- XTNT $122,298,000.00
- ATLX $587,122.00
- Revenue This Year
- XTNT $11.64
- ATLX $19,668.81
- Revenue Next Year
- XTNT $7.59
- ATLX $43.15
- P/E Ratio
- XTNT N/A
- ATLX N/A
- Revenue Growth
- XTNT 20.81
- ATLX 214.46
- 52 Week Low
- XTNT $0.33
- ATLX $3.54
- 52 Week High
- XTNT $0.80
- ATLX $13.70
- Technical
- Relative Strength Index (RSI)
- XTNT 44.76
- ATLX 66.08
- Support Level
- XTNT $0.56
- ATLX $3.80
- Resistance Level
- XTNT $0.67
- ATLX $4.25
- Average True Range (ATR)
- XTNT 0.05
- ATLX 0.25
- MACD
- XTNT -0.01
- ATLX 0.08
- Stochastic Oscillator
- XTNT 21.14
- ATLX 100.00
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.